Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
By temporarily suspending retinal activity in the non-amblyopic eye of animal models, neuroscientists restrengthened the visual response in the amblyopic eye, even at ages after the critical period when patch therapy fails.
The NEI has funded development of a handheld pediatric vision scanner that easily and accurately screens for amblyopia, or “lazy eye.” The device could facilitate earlier identification of children who need vision-saving treatment.
Researchers studying zebrafish have found that genes linked to autism spectrum disorder and other developmental brain abnormalities may be playing a role in people who cannot control their eye movements.
The standard treatment for amblyopia, a condition of poor vision in an otherwise healthy eye, is patching: covering a child’s better-seeing eye with a patch for two hours a day to improve vision in the weaker eye.
Three researchers supported in part by NEI have been elected to the National Academy of Sciences, a nonprofit organization that advises the U.S. government on matters of science and technology.
Surprising results from a nationwide clinical trial show that many children age seven through 17 with amblyopia (lazy eye) may benefit from treatments that are more commonly used on younger children.
